“pfizer” Archives

in
Entry Author Date Location
Exact Sciences Eyes Cologuard Market Expansion After “Landmark Year” 02/22/19 Wisconsin
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More 02/22/19 National
With Its First Human Data, Solid Slips in Duchenne Gene Therapy Race 02/07/19 Boston
Halozyme Gets $30M from Argenx in Licensing Deal Worth Up to $530M 02/06/19 San Diego
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More 02/01/19 National
Former Zavante Executive Tapped as Abide Therapeutics President 01/28/19 San Diego
WI Watchlist: Northwestern Mutual, Epic, Exact Sciences, Propeller 01/11/19 Wisconsin
Notes from the JPM19 Vortex: Price Apocalypse, Celgene Fallout & More 01/11/19 National
Bio Roundup: 2019 Trials, Pilgrim Price Chat, Pre-Xmas Sales & More 12/21/18 National
Pfizer, GSK to Merge Consumer Health Units, Focus on Prescription Drugs 12/19/18 National
15 For ’19: Key Clinical Data to Watch For Next Year (Part 2) 12/18/18 National
Kineta Gets $15M in New Cancer Drug Partnership with Pfizer 12/17/18 Seattle
15 for ’19: Key Clinical Data to Watch for Next Year (Part 1) 12/17/18 National
Merck Beefs Up Animal Health Unit with $2.4B Antelliq Acquisition 12/14/18 New York
GSK Pays $5.1B For Tesaro, Setting Up “PARP” Battle With Rival AstraZeneca 12/03/18 Boston
X4 Pharma Heads to Nasdaq Via Reverse Merger with Arsanis 11/27/18 Boston
ASH 2018: A Guide to the Latest for Blood-Borne Cancers and More 11/26/18 National
Bio Roundup: Moderna’s IPO, Arena’s Comeback, E-Cig Survey & More 11/16/18 National
Data Starts Stretch Run for UniQure’s Upgraded Hemophilia Gene Therapy 11/15/18 Boston
WI Watchlist: EatStreet, Exact Sciences, Northwestern Mutual & More 11/02/18 Wisconsin
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More 10/26/18 National
ESMO ’18: Precision Meds, Breast, Lung, and More from the Cancer Front 10/23/18 National
TP Therapeutics Names New CEO, Gets $80M More for Cancer Drug Push 10/19/18 San Diego
Bio Roundup: Prices on TV, Novartis Hearts Radio, Warp Drive’s End 10/19/18 National
Allogene’s IPO Raises $288M for Tests of “Off-the-Shelf” Cell Therapy 10/11/18 San Francisco
FDA OKs Akcea Rare Disease Drug, Setting Up Market Clash with Alnylam 10/05/18 Boston
Sarepta Touts New Data and a “Signal” With Duchenne Gene Therapy 10/03/18 Boston
Elanco IPO Raises $1.5B as the Animal Health Biz Spins Off from Lilly 09/20/18 Indiana
Allogene Files for IPO to Fund Cancer Cell Therapy Clinical Trials 09/14/18 San Francisco
Bio Roundup: A Gene Editing 1st, China Rises, Schenkein Steps Away 09/07/18 National
Page 1 of 29 next page »